JP2010090149A5 - - Google Patents

Download PDF

Info

Publication number
JP2010090149A5
JP2010090149A5 JP2009279362A JP2009279362A JP2010090149A5 JP 2010090149 A5 JP2010090149 A5 JP 2010090149A5 JP 2009279362 A JP2009279362 A JP 2009279362A JP 2009279362 A JP2009279362 A JP 2009279362A JP 2010090149 A5 JP2010090149 A5 JP 2010090149A5
Authority
JP
Japan
Prior art keywords
cooh
following formula
carbon atoms
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009279362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010090149A (ja
JP5603593B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010090149A publication Critical patent/JP2010090149A/ja
Publication of JP2010090149A5 publication Critical patent/JP2010090149A5/ja
Application granted granted Critical
Publication of JP5603593B2 publication Critical patent/JP5603593B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009279362A 2002-01-07 2009-12-09 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン Expired - Fee Related JP5603593B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34649202P 2002-01-07 2002-01-07
US60/346,492 2002-01-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003557380A Division JP4571408B2 (ja) 2002-01-07 2003-01-07 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013172071A Division JP2013237701A (ja) 2002-01-07 2013-08-22 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン

Publications (3)

Publication Number Publication Date
JP2010090149A JP2010090149A (ja) 2010-04-22
JP2010090149A5 true JP2010090149A5 (cg-RX-API-DMAC7.html) 2012-03-01
JP5603593B2 JP5603593B2 (ja) 2014-10-08

Family

ID=23359639

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2003557380A Expired - Lifetime JP4571408B2 (ja) 2002-01-07 2003-01-07 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン
JP2009279362A Expired - Fee Related JP5603593B2 (ja) 2002-01-07 2009-12-09 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン
JP2013172071A Pending JP2013237701A (ja) 2002-01-07 2013-08-22 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン
JP2015051753A Pending JP2015120745A (ja) 2002-01-07 2015-03-16 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003557380A Expired - Lifetime JP4571408B2 (ja) 2002-01-07 2003-01-07 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013172071A Pending JP2013237701A (ja) 2002-01-07 2013-08-22 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン
JP2015051753A Pending JP2015120745A (ja) 2002-01-07 2015-03-16 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン

Country Status (6)

Country Link
US (4) US6911471B2 (cg-RX-API-DMAC7.html)
EP (3) EP2462932A1 (cg-RX-API-DMAC7.html)
JP (4) JP4571408B2 (cg-RX-API-DMAC7.html)
AU (1) AU2003207455B2 (cg-RX-API-DMAC7.html)
CA (1) CA2472633C (cg-RX-API-DMAC7.html)
WO (1) WO2003057012A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462932A1 (en) * 2002-01-07 2012-06-13 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
AU2011204901B2 (en) * 2004-07-16 2013-09-12 Board Of Regents, The University Of Texas System Compounds and methods for treatment of cancer
TW201440760A (zh) * 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
WO2007027344A2 (en) 2005-07-29 2007-03-08 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
WO2007082104A2 (en) 2006-01-13 2007-07-19 The Texas A & M University System Compounds and methods for the treatment of cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
AU2007314076B2 (en) * 2006-11-01 2012-07-19 Newsouth Innovations Pty Limited Organo-arsenoxide compounds and use thereof
JP2011502985A (ja) 2007-11-02 2011-01-27 ジオファーム オンコロジー, インコーポレイテッド 有機ヒ素剤を使用する併用療法
KR20100097679A (ko) * 2007-12-12 2010-09-03 지오팜 온콜로지 인코포레이티드 암 치료 화합물 및 방법
WO2009153131A1 (en) * 2008-05-28 2009-12-23 Basf Se Means and methods for assessing liver enzyme induction
ES2901426T3 (es) * 2008-08-20 2022-03-22 Solasia Pharma K K Compuesto de organoarsénico para el tratamiento del cáncer
AU2011242988B2 (en) * 2010-04-19 2013-02-07 Sri International Compositions and method for the treatment of multiple myeloma
JP2016540775A (ja) * 2013-12-05 2016-12-28 ソレイジア・ファーマ株式会社 癌の処置のための化合物および方法
CN112941027B (zh) * 2021-03-19 2021-11-02 苏州大学 二甲基亚胂酸致人角质形成细胞恶性转化细胞株及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2349729A (en) * 1940-08-24 1944-05-23 Parke Davis & Co Therapeutic arsenic preparation
US2701812A (en) * 1951-06-26 1955-02-08 Dainippon Pharmaceutical Co Diarylarsenious acid derivatives and the preparation thereof
DE3229565A1 (de) * 1982-08-07 1984-02-16 Etschenberg, Eugen, Dr., 5000 Köln Arsenhaltige nucleoside
FR2640269B1 (fr) * 1988-12-13 1991-03-15 Maes Ludo Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
PT2018858E (pt) * 1997-10-15 2011-03-24 Polarx Biopharmaceuticals Inc Composições e métodos para o tratamento de doenças neoplásicas primárias e metastáticas usando compostos de arsénio
ES2395515T3 (es) 1997-11-10 2013-02-13 Memorial Sloan Kettering Cancer Center Trióxido de arsénico para uso en el tratamiento de la leucemia
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
AUPQ296799A0 (en) * 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
IL152433A0 (en) * 2000-04-26 2003-05-29 Univ Oregon Health Sciences Administration of a thiol-based chemoprotectant compound
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR598901A0 (en) 2001-06-28 2001-07-19 Unisearch Limited Inhibition of angiogenesis by targeting protein tyrosine phosphatases
JP4812249B2 (ja) 2001-07-06 2011-11-09 コクレア リミテッド 移植デバイスの構成
EP2462932A1 (en) * 2002-01-07 2012-06-13 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
JP4426456B2 (ja) 2002-11-07 2010-03-03 ニューサウス イノベイションズ ピーティーワイ リミテッド ミトコンドリア膜透過性遷移の誘導
TW201440760A (zh) 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
AU2007314076B2 (en) 2006-11-01 2012-07-19 Newsouth Innovations Pty Limited Organo-arsenoxide compounds and use thereof

Similar Documents

Publication Publication Date Title
JP2010090149A5 (cg-RX-API-DMAC7.html)
JP2009530398A5 (cg-RX-API-DMAC7.html)
JP2010077141A5 (cg-RX-API-DMAC7.html)
JP2013519632A5 (cg-RX-API-DMAC7.html)
JP2010523476A5 (cg-RX-API-DMAC7.html)
JP2012506896A5 (cg-RX-API-DMAC7.html)
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2016527277A5 (cg-RX-API-DMAC7.html)
JP2018524304A5 (cg-RX-API-DMAC7.html)
JP2016006096A5 (cg-RX-API-DMAC7.html)
JP2008509953A5 (cg-RX-API-DMAC7.html)
JP2012502037A5 (cg-RX-API-DMAC7.html)
JP2012512907A5 (cg-RX-API-DMAC7.html)
JP2013518107A5 (cg-RX-API-DMAC7.html)
RU2013119966A (ru) Композиция, улучшающая растворимость плохорастворимого лекарственного препарата
JP2011527345A5 (cg-RX-API-DMAC7.html)
JP2020097577A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
RU2011113967A (ru) Новое производное простагландина i2
JP2014505017A5 (cg-RX-API-DMAC7.html)
JP2008546770A5 (cg-RX-API-DMAC7.html)
JP2011046708A5 (cg-RX-API-DMAC7.html)
JP2014530818A5 (cg-RX-API-DMAC7.html)
JP2013518036A5 (cg-RX-API-DMAC7.html)